Literature DB >> 28233688

Weight loss and alterations in co-morbidities after revisional gastric bypass: A case-matched study from the Scandinavian Obesity Surgery Registry.

Stephan Axer1, Eva Szabo2, Ingmar Näslund2.   

Abstract

BACKGROUND: In Sweden, Roux-en-Y gastric bypass is the most common procedure when revising a previous bariatric procedure. This study is an analysis of all revisional gastric bypass operations (rGBP) compared with a matched group of primary gastric bypass (pGBP) operated between 2007 and 2012.
OBJECTIVE: The aim was to determine whether improvement of obesity-related co-morbidity and changes in weight after revisional gastric bypass surgery were comparable with those seen after primary surgery.
SETTING: 44 hospitals in Sweden
METHODS: Retrospective data were retrieved from the Scandinavian Obesity Surgery Registry. The study group (rGBP) comprised 1224 patients, and the control group (pGBP) comprised 3612 patients matched for age and gender.
RESULTS: The indication for revision was weight failure in 512 patients (42%), a late complication of the initial procedure in 330 patients (27%), and a combination of weight failure and complication in 303 patients (25%). A total of 66% of patients in the rGBP group and 67% in the pGBP group completed the 2-year follow-up in the Scandinavian Obesity Surgery Registry. The rGBP-group had significantly less excess BMI loss (%EBMIL 59.4±147.0 versus 79.5±24.7, P<.001) and a lower dyslipidemia remission rate (42.9% versus 62.0%, P = .005) at the time of the 2-year follow-up. Remission rates of sleep apnea, hypertension, type 2 diabetes, and depression were similar. The effects on obesity-related co-morbidity were not related to the indication for revisional surgery or the initial bariatric procedure.
CONCLUSION: Even if weight results might be inferior compared with primary bypass procedures, the improvement of co-morbidity is similar.
Copyright © 2017 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Co-morbidities; Diabetes; Gastric bypass; Revision; Weight loss

Mesh:

Year:  2017        PMID: 28233688     DOI: 10.1016/j.soard.2017.01.030

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  7 in total

1.  Secondary Bariatric Procedures in a High-Volume Centre: Prevalence, Indications and Outcomes.

Authors:  Mohamed Elshaer; Karim Hamaoui; Parushak Rezai; Kasim Ahmed; Nadira Mothojakan; Omer Al-Taan
Journal:  Obes Surg       Date:  2019-07       Impact factor: 4.129

Review 2.  Understanding Pathophysiological Concepts Leading to Obstructive Apnea.

Authors:  Eric Deflandre; Alexander Gerdom; Christine Lamarque; Bernard Bertrand
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

3.  Obstructive Sleep Apnea and Obesity: Implications for Public Health.

Authors:  Shazia Jehan; Ferdinand Zizi; Seithikurippu R Pandi-Perumal; Steven Wall; Evan Auguste; Alyson K Myers; Girardin Jean-Louis; Samy I McFarlane
Journal:  Sleep Med Disord       Date:  2017-12-12

Review 4.  Neuromodulation for the treatment of eating disorders and obesity.

Authors:  Darrin J Lee; Gavin J B Elias; Andres M Lozano
Journal:  Ther Adv Psychopharmacol       Date:  2017-12-08

Review 5.  Incidence of postoperative delirium in patients with preoperative and postoperative Obstructive Sleep Apnea Syndrome. A Systematic Review of the literature.

Authors:  S Dooijeweerd; Bart Torensma; D Faraj; A A Eldawlatly
Journal:  Saudi J Anaesth       Date:  2022-01-04

6.  Revisional Gastric Bypass Is Inferior to Primary Gastric Bypass in Terms of Short- and Long-term Outcomes-Systematic Review and Meta-Analysis.

Authors:  Michał Pędziwiatr; Piotr Małczak; Mateusz Wierdak; Mateusz Rubinkiewicz; Magdalena Pisarska; Piotr Major; Michał Wysocki; W Konrad Karcz; Andrzej Budzyński
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

7.  Energy imbalance: obesity, associated comorbidities, prevention, management and public health implications.

Authors:  Shazia Jehan; Ferdinand Zizi; Seithikurippu R Pandi-Perumal; Samy I McFarlane; Girardin Jean-Louis; Alyson K Myers
Journal:  Adv Obes Weight Manag Control       Date:  2020-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.